EUVIMED · CrossrefZeitschrift
Journal of Gynecologic Oncology
ISSN 2005-0380 · XMLink
Neueste Artikel
cfDNA-inferred putative clonal hematopoiesis during first-line platinum-to-PARP inhibitor maintenance in ovarian cancer
Distinct clinical and prognostic features of cervical neuroendocrine carcinoma: a nationwide registry-based study
Prognostic significance of peripheral serum inflammatory markers NLR and PLR in high-grade endometrial carcinoma: a multicenter retrospective study
Diagnostic and triage performance of CDO1 and CELF4 methylation in cervical exfoliated cells compared with serum biomarkers for endometrial cancer in abnormal bleeding women
Myometrial invasion and tumor free distance from serosa as prognostic factors in endometrial endometrioid carcinoma
Progression on PARP versus prior PARP exposure: interpreting subsequent platinum sensitivity in ovarian cancer
Is chemo-immunotherapy really beneficial for platinum-resistant ovarian cancer?
Subsequent primary cancer incidence in cervical cancer survivors: insights from a comprehensive cohort study utilizing combined Japanese population-based cancer registries
Distinct clinical and prognostic features of cervical adenosquamous carcinoma: a nationwide registry-based and propensity score-matched analysis
Diagnostic performance of cervical cytology in HPV-independent cervical cancer: a comparative analysis with HPV-associated cases
Comment of ‘Subsequent primary cancer incidence in cervical cancer survivors: insights from a comprehensive cohort study utilizing combined Japanese population-based cancer registries’
Reply to “Comment on ‘Subsequent primary cancer incidence in cervical cancer survivors: insights from a comprehensive cohort study utilizing combined Japanese population-based cancer registries’”
Pediatric non-gestational choriocarcinoma: a call for disease-specific treatment protocols
Reply to “Pediatric non-gestational choriocarcinoma: a call for disease-specific treatment protocols”
Prognostic imprecision and the cost-effectiveness of mismatch repair testing
Comments with ‘Cross-country inequalities and frontier analysis in global burden of cervical cancer: cross-sectional studies’
Response by Wang to “Post-PARP platinum resistance and biomarker re-evaluation in East Asian ovarian cancer cohorts”
Response by One et al. to “Post-PARP platinum resistance and biomarker re-evaluation in East Asian ovarian cancer cohorts”
Adjuvant treatment algorithm based on recent ESGO/ESTRO/ESP guidelines for early endometrial carcinoma according to prognostic risk groups
FUS-stabilized USP7 facilitates the bevacizumab resistance of ovarian cancer through deubiquitinating PTK2
The future of gynecologic oncologic surgery: a narrative review of current surgical trials
Cross-country inequalities and frontier analysis in global burden of cervical cancer: cross-sectional studies
Pattern of first recurrence in advanced epithelial ovarian, fallopian tube and peritoneal cancers treated with cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy
Trastuzumab deruxtecan in HER2-expressing gynecologic cancers from DESTINY-PanTumor02: antitumor activity, safety, and exploratory biomarker analyses
Neoadjuvant therapy of iparomlimab and tuvonralimab combined with chemotherapy-extenuated for locally advanced cervical cancer (NICE-CC): an investigator-initiated, multicentre, open-label, phase II trial
Impact of prior olaparib use on subsequent platinum-based therapy in recurrent ovarian cancer
PARP inhibitor maintenance takes advantages in advanced epithelial ovarian cancer but May show a negative impact while recurrence occurs: a multi-center retrospective study in Taiwan
Comprehensive assessment of incidence, mortality, and lifetime risk of ovarian cancer: a global study with forecasts to 2050
Pediatric non-gestational choriocarcinoma: systematic literature review and a multicenter case series
Effect of first-line poly(ADP-ribose) polymerase inhibitor on second-line platinum-based chemotherapy in epithelial ovarian cancer
EUVIMED